Company / Current Assets
Candel Therapeutics, Inc. Current Assets History
FY2021-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$36.8M
FY2023
5-year range
$36.8M / $84.9M
FY2021-FY2023
Trend
-48.9%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $85M to $37M over the past 2 years.
Based on SEC 10-K filings.
$37M in FY2023.
Declined from $85M to $37M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, current assets decreased 48.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -5.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $36.8M | -48.9% |
| FY2022 | $71.9M | -15.3% |
| FY2021 | $84.9M | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026